Teen's BMI drops from 36 to 22.8 after two years on Wegovy, ABC News reports
A 17-year-old boy, Adam Renteria, shared his experience with the GLP-1 medication Wegovy on Good Morning America, detailing how the drug helped him overcome lifelong obesity. His mother, Robin, noted significant behavioral changes, including reduced snacking and smaller meal portions. Over two years, Adam's body mass index dropped from 36 to 22.8, and he joined a cheer team, citing a major boost in confidence. While Wegovy is the only FDA-approved weekly GLP-1 for children over 12, experts caution that it is not a quick fix and may require long-term use. A NYU Langone study indicates pediatric prescriptions for the drug rose 310% between 2019 and 2026, despite overall low usage rates.
